Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
420 JPY | +1.69% | -1.18% | -40.46% |
Mar. 19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
Mar. 19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Sales 2024 | - | Sales 2025 * | - | Capitalization | 28.34B 181M |
---|---|---|---|---|---|
Net income 2024 | -2.64B -16.93M | Net income 2025 * | -3.3B -21.1M | EV / Sales 2024 | - |
Net cash position 2024 * | 5.65B 36.15M | Net Debt 2025 * | 226M 1.45M | EV / Sales 2025 * | - |
P/E ratio 2024 |
-14
x | P/E ratio 2025 * |
-8.42
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.15% |
Latest transcript on SanBio Company Limited
1 day | +1.21% | ||
1 week | -1.18% | ||
Current month | -6.07% | ||
1 month | -18.04% | ||
3 months | -26.80% | ||
6 months | -6.49% | ||
Current year | -40.46% |
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 13-02-28 |
Keita Mori
CEO | Chief Executive Officer | 56 | 13-02-26 |
Toru Kawanishi
CHM | Chairman | 56 | 13-02-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 420 | +1.69% | 183 800 |
24-04-25 | 413 | -2.13% | 360,200 |
24-04-24 | 422 | +1.20% | 493,100 |
24-04-23 | 417 | -0.48% | 248,600 |
24-04-22 | 419 | -0.95% | 424,000 |
Delayed Quote Japan Exchange, April 26, 2024 at 01:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.46% | 182M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- 4592 Stock